SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir shares are seeing muted volatility despite a significant earnings beat and raised full-year guidance, leaving the community divided between those celebrating the company's accelerating commercial growth and those wary of its premium valuation. While bulls highlight the strong revenue and government contract momentum, bears are pointing to the stock's high P/E ratio and the potential for options-related price suppression by market makers.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending as traders speculate on a potential short squeeze, driven by its extremely low float and increasing momentum. The community is actively discussing the potential for a parabolic breakout, with many investors holding overnight positions while drawing comparisons to previous low-float market runners.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is seeing intense debate as investors weigh strong engagement and elite profitability metrics against slowing growth trajectories and the broader fear that AI disruption is eroding the platform's long-term moat. While the stock faces heavy selling pressure and a bearish narrative, a vocal contingent of investors views current price levels as a generational buying opportunity, citing aggressive share buybacks and a dominant market position.

SKK Holdings Ltd. operates as a holding company, which engages in the provision of civil engineering services in subsurface utility works, including power and telecommunication cable laying, water pipeline and sewer rehabilitation works. The company was founded by Chun Seong Ng and Koon Kiat Sze on October 16, 2013 and is headquartered in Singapore.

SKK Holdings Ltd. - Ordinary Shares - Class A

SKK Holdings Ltd

SKK Holdings is experiencing extreme volatility and rapid price appreciation driven by a major drone asset acquisition agreement, leading to a polarized community debate between traders capitalizing on the micro-float momentum and skeptics warning of potential dilution risks. Investors are actively discussing the stock's thin float, frequent trading halts, and its potential to replicate the parabolic moves of other low-float runners, while critics emphasize concerns over the company's past financial performance and the long-term impact of its acquisition strategy.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

Xanadu Quantum Technologies is experiencing extreme volatility driven by the expiration of post-SPAC lock-up periods, which triggered a massive influx of available shares and intense speculative trading. While some investors fear significant dilution and see a potential for a long-term price reset, others are actively debating whether the sell-off is a panic-induced overreaction that creates a prime opportunity for a short squeeze or a bargain entry point.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle ($CRCL) is rallying as investors react to bipartisan progress on the CLARITY Act, which clarifies regulatory guidelines for stablecoins and eases long-standing industry uncertainty. The community is actively debating whether this momentum marks a sustainable breakout for crypto-related infrastructure or if the stock faces consolidation before a potential next leg higher.

Pinterest, Inc. engages in the operation of a pinboard-style photo-sharing website. It allows users to create and manage theme-based image collections such as events, interests, and hobbies. The company was founded by Benjamin Silbermann, Paul Cahill Sciarra, and Evan Sharp in October 2008 and is headquartered in San Francisco, CA.

Pinterest Inc - Ordinary Shares - Class A

Pinterest Inc

Pinterest is trending following an aggressive $1 billion investment from Elliott Investment Management and the announcement of a massive $3.5 billion share repurchase program, sparking community debate over the company's long-term valuation. Investors are actively discussing whether this influx of capital and the focus on buybacks will stabilize the stock or if the company remains a potential M&A target.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is trending due to a significant increase in contract awards and aggressive debt reduction, sparking investor interest as the sector prepares for its upcoming merger. The community is actively discussing the stock's role in the global energy supply chain amid geopolitical tensions, with many traders focused on the potential for a short squeeze as the company strengthens its backlog and operational position.

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Cns Pharmaceuticals Inc

Cns Pharmaceuticals is seeing intense volatility and massive volume following an oversubscribed private placement financing, sparking heavy retail interest. The community is actively debating the stock's potential for further squeeze-driven gains versus the risks of dilution, with many focusing on its low float and ongoing technical battles between bulls and short sellers.

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Holdings Corp - Ordinary Shares - Class A

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) is experiencing significant downward pressure following a double-beat earnings report that resulted in a sharp selloff, leaving investors to debate whether the stock is fundamentally overvalued or if the post-earnings decline represents a buying opportunity. Community sentiment is deeply divided, with many participants citing aggressive insider buying as a signal to hold, while skeptics warn of potential further volatility and ongoing concerns regarding the company's valuation and growth sustainability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Inspire Medical Systems (NYSE:INSP) Issues Quarterly Earnings Results

Inspire Medical Systems (NYSE:INSP - Get Free Report) released its earnings results on Monday. The company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of ($0.28) by...

Inspire Medical Systems (NYSE:INSP) Releases FY 2026 Earnings Guidance

Inspire Medical Systems (NYSE:INSP) updated its FY 2026 earnings guidance. The company provided EPS guidance of 0.750-1.250 for the period, compared to the consensus estimate of 1.990. The company also issued revenue guidance of $825.0 millionillion-$875.0 millionillion, compared to the...

Inspire Medical Systems, Inc. (NYSE:INSP) Receives Consensus Rating of "Hold" from Analysts

Shares of Inspire Medical Systems, Inc. (NYSE:INSP - Get Free Report) have been given an average recommendation of "Hold" by the nineteen analysts that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, thirteen have given a...

Inspire Medical Systems AGM: 2025 Revenue Hits $912M as Shareholders OK Governance, Equity Plan

Inspire Medical Systems (NYSE:INSP) highlighted revenue growth, product innovation, and a series of governance and compensation-related items that won stockholder approval at its 2026 annual meeting held virtually on April 30, 2026.

Management highlights 2025 performance and milestones
Timothy P. H...

Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates

Pulmonx (LUNG) delivered earnings and revenue surprises of 0.00% and +2.52%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Tempus AI (TEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Tempus (TEM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Inspire Medical Systems (INSP) to Report a Decline in Earnings: What to Look Out for

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Inspire Medical Systems (NYSE:INSP) Shares Down 8.3% - Time to Sell?

Inspire Medical Systems (NYSE:INSP) Shares Down 8.3% - Here's Why...

Inspire Medical Systems (NYSE:INSP) Cut to "Hold" at Zacks Research

Zacks Research cut Inspire Medical Systems from a "strong-buy" rating to a "hold" rating in a research report on Tuesday...

Inspire Medical Systems (NYSE:INSP) Price Target Cut to $64.00 by Analysts at Truist Financial

Truist Financial cut their target price on shares of Inspire Medical Systems from $70.00 to $64.00 and set a "hold" rating on the stock in a research note on Wednesday...

$INSP Q1 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.39 down -490.00% YoY
• Reported revenue of $204.58M up 1.62% YoY
• Inspire Medical Systems anticipates revenue will continue to be adversely impacted during 2026 due to ongoing coding and reimbursement uncertainty, the WISeR program, and the increasing adoption of GLP-1s in the short-term.

Stocktwits

Inspire Medical Systems Inc

 Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.39 down -490.00% YoY
• Reported revenue of $204.58M up 1.62% YoY
• Inspire Medical Systems anticipates revenue will continue to be adversely impacted during 2026 due to ongoing coding and reimbursement uncertainty, the WISeR program, and the increasing adoption of GLP-1s in the short-term.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Current Price	$54.84
Prev Close	$56.70
Open	$56.73
Dividend Yield	0.00%
50-Day Moving Average	$56.78
Beta	1.14
Avg. Volume	942,933.24
PE Ratio	11.42

52-Week High	$163.35
52-Week Low	$48.30
Market Capitalization	$1.63B
EPS (Annual)	$4.89
Price to Book	2.07
Revenue Per Employee	$684,156.79

INSP
Inspire Medical Systems Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INSP News

INSPInspire Medical Systems Inc